Print

Harvard Bioscience Inc. (HBIO) Names Robert E. Gagnon as Chief Financial Officer  
10/16/2013 9:53:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HOLLISTON, Mass., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has hired Robert E. Gagnon, a veteran financial executive, as Harvard Bioscience's Chief Financial Officer, effective as of the date of HBIO's planned spin-off of Harvard Apparatus Regenerative Technology, Inc., or HART, which is anticipated to be November 1, 2013, or the Distribution Date. From October 23, 2013 until the Distribution Date, Mr. Gagnon will initially serve as HBIO's Executive Vice President – Finance.

Help employers find you! Check out all the jobs and post your resume.

//-->